Intrinsic Edge Capital Management LLC Accelerate Diagnostics, Inc Transaction History

Intrinsic Edge Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$16.62 - $23.92 $3.99 Million - $5.74 Million	-240,000 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$11.76 - $22.15 $470,400 - $886,000	40,000 Added 20.0%	240,000 $5.05 Million
Q4 2018 Feb 14, 2019	BUY	$10.42 - $21.94 $1.1 Million - $2.32 Million	105,760 Added 112.22%	200,000 $2.3 Million
Q3 2018 Nov 14, 2018	BUY	$20.4 - $24.6 $290,496 - $350,304	14,240 Added 17.8%	94,240 $2.16 Million
Q2 2018 Aug 14, 2018	BUY	$19.02 - $24.95 $951,000 - $1.25 Million	50,000 Added 166.67%	80,000 $1.78 Million
Q4 2017 Feb 14, 2018	SELL	$18.0 - $30.0 $1.3 Million - $2.16 Million	-72,082 Reduced 70.61%	30,000 $786,000
Q3 2017 Nov 14, 2017	BUY	$21.1 - $25.15 $2.15 Million - $2.57 Million	102,082	102,082 $2.29 Million

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $162M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Intrinsic Edge Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Intrinsic Edge Capital Management LLC with notifications on news.